comparemela.com
  1. Home
  2. Live Updates
  3. Sciences In Prof - Breaking News

Latest Breaking News On - Sciences in prof - Page 1 : comparemela.com

PharmAla Files IP Protection For Novel MDXX Molecule: Viability As Autism Spectrum Treatment - Pharmala Biotech Hldgs (OTC:PMBHF)

Canadian biotech company PharmAla Biotech Holdings (OTC: PMBHF) has filed a patent covering composition of matter of Novel Chemical Entity (NCE) PharmAla-1. 

New south walesNick kadyshWilliam fantegrossiHarpreet kaurSciences in profUniversity of windsorUniversity of arkansasUniversity of sydneyPharmala biotechNovel chemical entityMedical sciencesEntactogens and classical psychedelicsNew publishedAutism spectrum disorder

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.